• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
Swiss National Bank (SNB) Governing Council member Tschudin: The SNBs interest rate cuts are stimulating credit growth as expected.November 14th - Most Canadians believe that a trade agreement with the United States is unlikely within the next six months. This comes after US President Trump halted negotiations due to an anti-tariff advertising campaign launched by Ontario. According to a poll conducted by the Nanos Research Group, approximately 67% of Canadians said it was "unlikely" to reach an agreement to lower US tariffs within the next six months, 28% thought it was "possible," and 3% were unsure. Canadian Prime Minister Carney previously stated that negotiations were progressing towards agreements on steel, aluminum, and energy. The survey suggests that Canadians may understand why Carney has so far failed to reach an agreement with the erratic US president. However, as the trade impasse continues and economic pressures intensify, their patience may gradually wear thin.Volkswagens supervisory board has postponed approval of the investment plan.EIA report: U.S. oil production hit a record high last week after the agency raised its production forecast following a benchmarking change.On November 14, staff from the International Monetary Fund (IMF) urged the Argentine government of Miguel Millais to accelerate the accumulation of foreign exchange reserves as part of a $20 billion agreement between the country and the IMF. The IMFs warning further exacerbates the debate between Millaiss team and some investors over whether the government needs a comprehensive reform of its monetary policy—a policy that has been a fatal weakness in Argentinas past collaborations with the IMF. IMF spokesperson Julie Kozak stated, "In our discussions with the authorities, we emphasized the need to accelerate reserve accumulation to better manage volatility and further enhance market confidence. The IMFs view is that the chosen policy framework must be consistent with strengthening international reserves and maintaining external stability, while ensuring strong and sustainable growth for the country."

Goldman Sachs Has Improved Humana's Competitive Standing

Aria Thomas

Dec 14, 2022 10:41

2.png


Goldman Sachs analysts upgraded shares of Humana (NYSE:HUM) to Buy with a $652 price target in a research note published on Tuesday.


The company's improved "competitive positioning in MA and underappreciated HC Services opportunity should outweigh the potential RADV impact," which Goldman Sachs estimates to range between $2.6 and $5.8 billion (NPV) before offsetting factors.


Analysts stated, "We see a strengthening earnings outlook as a result of improved competitive positioning in Massachusetts, which has reaccelerated member growth for 2023 and could lead to multiple years of share gains in 2024 when many competitors will face Stars headwinds." "We also see an attractive and undervalued opportunity in the health care services sector, with primary care earnings having the potential to outperform its September guidance,"


While analysts assert that the company is aware of the significant risk posed by the forthcoming RADV ruling, their EPS estimates for 2024-2025 are 4% higher than the industry average.


This reflects "3% higher member growth and a primary care EBITDA opportunity of $205mn-$395mn for 2025," which is "above the company's $100-$200mn outlook in its mid-term guidance, with more of this EBITDA hitting the P&L as WCAS centers come onto the balance sheet."


"Despite the stock's outperformance in 2022 (+18% YTD vs. MCO group +13%), the stock trades in line with its historical median despite higher forward EPS CAGR of 15% vs. its 3-year history of 12%," concluded the analysts.